Medication Alerts Digest · Apr 11 Daily Digest
Key Drug Recalls
- 🔥 Prazosin: Another recall linked to N-nitroso-prazosin impurity C, with an acceptable limit of 5 ppm according to the CA...

Created by Natasha Easton
Prescription and OTC drug safety updates, recalls, and chronic disease guidance
Explore the latest content tracked by Medication Alerts Digest
Menopause relief rebounds with estradiol prescriptions jumping to 32 million last year from 18 million in 2021, fueling a $6.3B market.
Critical recall alert: 3.1 million bottles of eye drops sold at pharmacies and grocery stores are being recalled. Patients and caregivers: immediately check labels on your OTC eye drops and dispose if affected to avoid risks.
Patient safety first: Over 3.1 million bottles of OTC eye drops from KC Pharmaceuticals recalled due to lack of sterility assurance, sold at CVS,...
Compounded GLP-1s pose severe risks – unregulated with contamination and potency issues, unlike FDA-approved options.
Heart disease kills one person every 34 seconds in the US. New uniform recommendations for doctors explain what this means for patients.
Urgent recall of specific Omnipod 5 Pod lots due to internal tubing tears causing insulin leaks and under-delivery risks.
Wave of FDA safety actions hits chronic care and OTC products:
Key guidance for diabetes caregivers on DME eye treatment escalation to protect vision: